This latest research further confirms that breast MRI not only detects tumors that mammography cannot, but it also spots invasive cases that pose greater risks to patients. 

A general lack of awareness pertaining to ACR appropriateness criteria could be a driving factor behind the misguided requisitions, authors of a new analysis suggest. 

In other news, West Physics Consulting is acquiring part of Tricord Inc., while radiology appointment scheduling firm CCD Health was recently sold. 

Advanced imaging equipment using ionizing radiation enters the global market at the rate of one new technology every five years.

Is portable MRI suitable for finding abnormalities in the brains of patients receiving new amyloid-targeting therapy for Alzheimer’s disease? Clinical researchers are about to find out.

Ezra charges $950 to $2,500 for exams of healthy individuals and analyzes them with its FDA-cleared software to diagnose cancer and other conditions.  

The two companies have partnered on a new FDA-cleared CT injection system for the early detection of breast cancer.

The case dates to March 2020, when the University of South Florida Foundation filed suit against the Marlborough, Massachusetts-based company, which later countersued.